Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03812731Completed
Randomised, open-label trial of ropivacaine in pain (2 arms), sponsored by Sir Ganga Ram Hospital. Primary endpoint: Incidence of urethrocutaneous fistula at 3 months. Started Feb 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03812731.